Property:Cancer stage specification
Appearance
This is a property of type Text.
D
Tx-T4 (50% T2), N0-N3 (55.6% N0), Mx-M1 (83.3% M0) +
E
Ehrenpreis et al. (2005): A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Retinol Palmitate (Vitamin A) for Symptomatic Chronic Radiation Proctopathy +
NI +
Emami et al. (2014): Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of green tea in preventing acute gastrointestinal complications due to radiotherapy +
NI +
Ertekin et al. (2004): Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study +
NI +
F
Fahimi et al. (2011): Evaluating the Effect of Zingiber Officinalis on Nausea and Vomiting in Patients Receiving Cisplatin Based Regimens +
NI +
Fallahi et al. (2013): Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer? +
NI +
Fallon et al. (2017) I: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
Mean (SD) time since cancer diagnosis per arm:
Sativex = 4.1 (4.2) years
Placebo = 3.5 (5.0) years +
Fallon et al. (2017) II: Sativex oromucosal spray as adjunctive therapy in advanced cancer patients with chronic pain unalleviated by optimized opioid therapy: two double-blind, randomized, placebo-controlled phase 3 studies +
NI +
Ferreira et al. (2004): Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial +
III and IV +
Frankling et al. (2021): ‘Palliative-D’ - Vitamin D Supplementation to Palliative Cancer Patients: A Double Blind, Randomized Placebo-Controlled Multicenter Trial +
Advanced and/or metastatic cancer in palliative phase +
Freedland et al. (2020): A Randomized Controlled Trial of a 6-month low carbohydrate intervention on disease progression in men with recurrent prostate cancer: Carbohydrate and Prostate Study 2 (CAPS2) +
NI +
G
Ghoreishi et al. (2007): Effect of vitamin E on chemotherapy-induced mucositis and neutropenia in leukemic patients undergoing bone marrow transplantation +
NA +
Goossens et al. (2016): Phase III randomised chemoprevention study with selenium on the recurrence of non-invasive urothelial carcinoma. The SELEnium and BLAdder cancer Trial +
Transurethral resected urinary bladder carcinoma (non-invasive urinary bladder carcinoma, Ta, T1, Tis) +
Gorgu et al. (2013): The effect of zinc sulphate in the prevention of radiation induced oral mucositis in patents with head and neck cancer +
Radiotherapy field >33% of the buccal mucosa and ECOG 0‐2 +
Grimison et al. (2020): Oral THC:CBD cannabis extract for refractory chemotherapy-induced nausea and vomiting: a randomised, placebo-controlled, phase II crossover trial +
Any malignancy of any stage +
Gujral et al. (2001): Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers +
Enzyme-arm: T-Stage 0=2 T-Stage 1=1 T-Stage 2=26 T-Stage 3=13 T-Stage 4=11
Control-arm: T-Stage 0=4 T-Stage 1=3 T-Stage 2=18 T-Stage 3=8 T-Stage 4=14
Enzyme-arm: N-Stage 0=17 N-Stage 1=23 N-Stage 2=10 N-Stage 3=2 N-Stage x=1
Control-arm: N-Stage 0=18 N-Stage 1=18 N-Stage 2=11 N-Stage 3=0 N-Stage x=0
Site of disease per arm:
Alveolo-buccal: Enyzme-arm=21; control-arm=23
Tongue: Enzyme-arm=19; control-arm=19
Others: Enzyme-arm=13; control-arm=12 +
H
Hajimohammadebrahim-Ketabforoush et al. (2019): Effect of Vitamin D Supplementation on Postcraniotomy Pain After Brain Tumor Surgery: A Randomized Clinical Trial +
NI +
Halyard et al. (2007): Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4) +
NI +
Heggie et al. (2002): A phase III study on the efficacy of topical aloe vera gel on irradiated breast tissue +
T-Stage per arm:
Aloe vera arm: 1 = 67; 2 = 38; 3 = 2; unknown = 0
Placebo arm: 1 = 67; 2 = 29; 3 = 1; unknown = 4 +